Management of asymptomatic arrhythmias – a shortened and commented consensus document of the European Heart Rhythm Association (EHRA)
Authors:
Heinc P.; Hudec Š.; Aiglová R.; Vícha M.; Jelínek L.; Rec L.
Authors‘ workplace:
I. interní klinika – kardiologická LF UP a FN Olomouc
Published in:
Kardiol Rev Int Med 2019, 21(4): 199-208
Overview
Asymptomatic cardiac arrhythmias may in fact have worse consequences than symptomatic arrhythmias, as they are often detected only in severe medical complications associated with unrecognised arrhythmias. In clinical practice, the incidence of asymptomatic arrhythmias is quite frequent, but these specific conditions do not have any recommended procedures for their resolution. This review summarises the current evidence needed for optimal management of asymptomatic arrhythmias, if any, and/or provides EHRA professional consensus to solve this problem if the evidence is insufficient or inconsistent.
Keywords:
atrial fibrillation – asymptomatic arrhythmias – tachycardia induced cardiomyopathy – ectopy – preexcitation – bradycardia
Sources
1. Arnar DO, Mairesse GH, Calkins H et al. Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS). Europace 2019. pii: euz046. doi: 10.1093/ europace/ euz046.
2. Weber BE, Kapoor WN. Evaluation and outcomes of patients with palpitations. Am J Med 1996; 100(2): 138– 148. doi: 10.1016/ s0002-9343(97)89451-x.
3. Strickberger SA, Ip J, Saksena S et al. Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm 2005; 2(2): 125– 131. doi: 10.1016/ j.hrthm.2004.10.042.
4. Shen MJ, Zipes DP. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circ Res 2014; 114(6): 1004– 1021. doi: 10.1161/ CIRCRESAHA.113.302549.
5. Schwartz PJ. Cardiac sympathetic denervation to prevent life-threatening arrhythmias. Nat Rev Cardiol 2014; 11(6): 346– 353. doi: 10.1038/ nrcardio.2014.19.
6. Wieling W, Thijs RD, van Dijk N et al. Symptoms and signs of syncope: a review of the link between physiology and clinical clues. Brain 2009; 132 (Pt 10): 2630– 2642. doi: 10.1093/ brain/ awp179.
7. Binici Z, Intzilakis T, Nielsen OW et al. Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation 2010; 121(17): 1904– 1911. doi: 10.1161/ CIRCULATIONAHA.109.874982.
8. Suzuki S, Sagara K, Otsuka T et al. Usefulness of frequent supraventricular extrasystoles and a high CHADS2 score to predict first-time appearance of atrial fibrillation. Am J Cardiol 2013; 111(11): 1602– 1607. doi: 10.1016/ j.amjcard.2013.01.335.
9. Dewland TA, Vittinghoff E, Mandyam MC et al. Atrial ectopy as a predictor of incident atrial fibrillation: a cohort study. Ann Intern Med 2013; 159(11): 721– 728. doi: 10.7326/ 0003-4819-159-11-2013120 30-00004.
10. Larsen BS, Kumarathurai P, Falkenberg J et al. Excessive atrial ectopy and short atrial runs increase the risk of stroke beyond incident atrial fibrillation. J Am Coll Cardiol 2015; 66(3): 232– 241. doi: 10.1016/ j.jacc.2015.05.018.
11. Davidoff R, Schamroth CL, Myburgh DP. The Wolff-Parkinson-White pattern in health aircrew. Aviat Space Environ Med 1981; 52(9): 554– 558.
12. Munger TM, Packer DL, Hammill SC et al. A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953– 1989. Circulation 1993; 87(3): 866– 873. doi: 10.1161/ 01.cir.87.3.866.
13. Leitch JW, Klein GJ, Yee R et al. Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern. Circulation 1990; 82(5): 1718– 1723. doi: 10.1161/ 01.cir.82.5.1718.
14. Obeyesekere MN, Leong-Sit P, Massel D et al. Risk of arrhythmia and sudden death in patients with asymptomatic preexcitation: a meta-analysis. Circulation 2012; 125(19): 2308– 2315. doi: 10.1161/ CIRCULATIONAHA.111.055350.
15. Blomström-Lundqvist C, Scheinman MM, Aliot EMet al. ACC/ AHA/ ESC guidelines for the management of patients with supraventricular arrhythmias – exe-cutive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation 2003; 108(15): 1871– 1909. doi: 10.1161/ 01.CIR.0000091380.04100.84.
16. Katritsis DG, Boriani G, Cosio FG et al. European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). Europace 2017; 19(3): 465– 511. doi: 10.1093/ europace/ euw301.
17. Santinelli V, Radinovic A, Manguso F et al. The natural history of asymptomatic ventricular pre-excitation a long-term prospective follow-up study of 184 asymptomatic children. J Am Coll Cardiol 2009; 53(3): 275– 280. doi: 10.1016/ j.jacc.2008.09.037.
18. Kubuš P, Vít P, Gebauer RA et al. Electrophysiologic profile and results of invasive risk stratification in asymptomatic children and adolescents with the Wolff-Parkinson-White electrocardiographic pattern. Circ Arrhythm Electrophysiol 2014; 7(2): 218– 223. doi: 10.1161/ CIRCEP.113.000930.
19. Mairesse GH, Moran P, Van Gelder IC et al. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). Europace 2017; 19(10): 1589– 1623. doi: 10.1093/ europace/ eux177.
20. Kirchhof P, Benussi S, Kotecha D et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 2016; 18(11): 1609– 1678. doi: 10.1093/ europace/ euw295.
21. Gorenek BC, Bax J, Boriani G et al. Device detected subclinical atrial tachyarrhythmias: definition, implications and management – an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). Europace 2017; 19(9): 1556– 1578. doi: 10.1093/ europace/ eux163.
22. Esato M, Chun YH, An Y et al. Clinical impact of asymptomatic presentation status in patients with paroxysmal and sustained atrial fibrillation: the Fushimi AF registry. Chest 2017; 152(6): 1266– 1275. doi: 10.1016/ j.chest.2017.08.004.
23. Hindricks G, Piorkowski C, Tanner H et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation 2005; 112(3): 307– 313. doi: 10.1161/ CIRCULATIONAHA.104.518837.
24. Ganesan AN, Chew DP, Hartshorne T et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur Heart J 2016; 37(20): 1591– 1602. doi: 10.1093/ eurheartj/ ehw007.
25. Potpara TS, Polovina MM, Marinkovic JM et al. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study. Int J Cardiol 2013; 168(5): 4744– 4749. doi: 10.1016/ j.ijcard.2013.07.234.
26. Calkins H, Hindricks G, Cappato R et al. HRS/ EHRA/ ECAS/ APHRS/ SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace 2017; 20(1): e1– e160. doi: 10.1093/ europace/ eux274.
27. Kalman JM, Sanders P, Rosso R et al. Should we perform catheter ablativ for asymptomatic atrial fibrillation? Circulation 2017; 136(5): 490– 499. doi: 10.1161/ CIRCULATIONAHA.116.024926.
28. Wu L, Lu Y, Zheng L et al. Comparison of radiofrequency catheter ablation between asymptomatic and symptomatic persistent atrial fibrillation: a propensity score matched analysis. J Cardiovasc Electrophysiol 2016; 27(5): 531– 535. doi: 10.1111/ jce.12930.
29. Healey JS, Connolly SJ, Gold MR et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012; 366(2): 120– 129. doi: 10.1056/ NEJMoa1105575.
30. Martin DT, Bersohn MM, Waldo AL et al. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J 2015; 36(26): 1660– 1668. doi: 10.1093/ eurheartj/ ehv115.
31. Lee V, Perera D, Lambiase P. Prognostic significance of exercise-induced premature ventricular complexes: a systematic review and meta-analysis of observational studies. Heart Asia 2017; 9(1): 14– 24. doi: 10.1136/ heartasia-2016-01085.
32. Lin CY, Chang SL, Chung FP et al. Long-term outcome of non-sustained ventricular tachycardia in structurally normal hearts. PLoS One 2016; 11(8): e0160181. doi: 10.1371/ journal.pone.0160181. eCollection 2016.
33. Novak J, Zorzi A, Castelletti S et al. Electrocardiographic differentiation of idiopathic right ventricular outflow tract ectopy from early arrhythmogenic right ventricular cardiomyopathy. Europace 2017; 19(4): 622– 628. doi: 10.1093/ europace/ euw018.
34. Al-Khatib SM, Stevenson WG, Ackerman MJ et al. AHA/ ACC/ HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation 2018; 138(13): e272– e391. doi: 10.1161/ CIR.0000000000000549.
35. Del Carpio Munoz F, Syed FF, Noheria A et al. Characteristics of premature ventricular complexes as correlates of reduced left ventricular systolic function: study of the burden, duration, coupling interval, morphology and site of origin of PVCs. J Cardiovasc Electrophysiol 2011; 22(7): 791– 798. doi: 10.1111/ j.1540-8167.2011.02021.x.
36. Dukes JW, Dewland TA, Vittinghoff E et al. Ventricular ectopy as a predictor of heart failure and death. J Am Coll Cardiol 2015; 66(2): 101– 109. doi: 10.1016/ j.jacc.2015.04.062.
37. Hasdemir C, Ulucan C, Yavuzgil O et al. Tachycardia-induced cardiomyopathy in patients with idiopathic ventricular arrhythmias: the incidence, clinical and electrophysiologic characteristics, and the predictors. J Cardiovasc Electrophysiol 2011; 22(6): 663– 668. doi: 10.1111/ j.1540-8167.2010.01986.x.
38. Nakahara S, Chien C, Gelow J et al. Ventricular arrhythmias after left ventricular assist device. Circ Arrhythm Electrophysiol 2013; 6(3): 648– 654. doi: 10.1161/ CIRCEP.113.000113.
39. MacLellan-Tobert SG, Porter CJ. Accelerated idioventricular rhythm: a benign arrhythmia in childhood. Pediatrics 1995; 96(1 Pt 1): 122– 125.
40. Maury P, Baratto F, Zeppenfeld K et al. Radiofrequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%. Eur Heart J 2014; 35(22): 1479– 1485. doi: 10.1093/ eurheartj/ ehu040.
41. Corrado D, Wichter T, Link MS et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/ dysplasia: an International Task Force Consensus Statement. Circulation 2015; 132(5): 441– 453. doi: 10.1161/ CIRCULATIONAHA.115.017944.
42. Donghua Z, Jian P, Zhongbo X et al. Reversal of cardiomyopathy in patients with congestive heart failure secondary to tachycardia. J Interv Card Electrophysiol 2013; 36(1): 27– 32: discussion 32. doi: 10.1007/ s10840-012-9727-9.
43. Kang KT, Potts JE, Radbill AE et al. Permanent junctional reciprocating tachycardia in children: a multicenter experience. Heart Rhythm 2014; 11(8): 1426– 1432. doi: 10.1016/ j.hrthm.2014.04.033.
44. Hilgard J, Ezri MD, Denes P. Significance of ventricular pauses of three seconds or more detected on twenty-four-hour Holter recordings. Am J Cardiol 1985; 55(8): 1005– 1008. doi: 10.1016/ 0002-9149(85)90735-0
Labels
Paediatric cardiology Internal medicine Cardiac surgery CardiologyArticle was published in
Cardiology Review
2019 Issue 4
Most read in this issue
- Indapamide is not only a diuretic
- Propafenone
- News in the treatment of dyslipidaemia
- Management of asymptomatic arrhythmias – a shortened and commented consensus document of the European Heart Rhythm Association (EHRA)